XML 53 R37.htm IDEA: XBRL DOCUMENT v3.3.1.900
Quarterly Information (Unaudited) (Tables)
12 Months Ended
Dec. 31, 2015
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Quarterly Financial Information
The following interim financial information presents the 2015 and 2014 results of operations on a quarterly basis:
2015
 
March 31 
 
June 30 
 
September 30 
 
December 31 
 
 
(Dollars in millions, except per share data)
 
Total revenues
$
3,889.9

 
$
4,163.6

 
$
4,153.7

 
$
4,036.4

 
Health plan services costs
3,142.9

 
3,363.7

 
3,318.4

 
3,216.0

 
Government contracts costs
142.5

 
137.3

 
158.1

 
165.9

 
Income from operations before income taxes
67.7

(1) (2)
132.1

(3) (4)
153.3

(5) (6)
101.5

(7) (8)
Net income
30.0

(1) (2)
58.4

(3) (4)
60.3

(5) (6)
37.1

(7) (8)
Basic earnings per share
$
0.39

 
$
0.76

 
$
0.78

 
$
0.48

 
Diluted earnings per share (9)
$
0.38

 
$
0.75

 
$
0.77

 
$
0.47

 
 
__________
(1) Includes $57.8 million amortization of deferred costs of health insurer's fee and $20.8 million in other ACA fees.
(2) Includes $1.9 million pretax asset impairment and $44.3 million in pretax expenses primarily related to the Cognizant Transaction.
(3)
Includes $58.5 million amortization of deferred costs of health insurer's fee and $21.5 million in other ACA fees.
(4) Includes $26.4 million in pretax expenses primarily related to the Cognizant Transaction.
(5) Includes $58.4 million amortization of deferred costs of health insurer's fee and $22.2 million in other ACA fees.
(6) Includes $21.7 million in pretax expenses primarily related to the Cognizant Transaction.
(7) Includes $58.2 million amortization of deferred costs of health insurer's fee and $21.1 million in other ACA fees.
(8) Includes $22.7 million in pretax expenses primarily related to the Cognizant Transaction.
(9) The sum of the quarterly amounts may not equal the year-to-date amounts due to rounding.

2014
 
March 31 
 
June 30 
 
September 30 
 
December 31 
 
 
(Dollars in millions, except per share data)
 
Total revenues
$
3,038.9

 
$
3,421.4

 
$
3,789.9

 
$
3,758.4

 
Health plan services costs
2,402.3

 
2,763.2

 
3,104.0

 
3,038.2

 
Government contracts costs
132.0

 
133.2

 
124.4

 
147.1

 
Income from operations before income taxes
62.0

(1)
98.8

(2)
22.7

(4) (5)
16.3

(6) (7)
Net income
28.8

(1)
120.9

(2) (3)
(8.9
)
(4) (5)
4.9

(6) (7)
Basic earnings per share
$
0.36

 
$
1.51

 
$
(0.11
)
 
$
0.06

 
Diluted earnings (loss) per share (8)
$
0.36

 
$
1.49

 
$
(0.11
)
 
$
0.06

 
 
__________
(1) Includes $36.3 million amortization of deferred costs of health insurer's fee and $22.5 million in other ACA fees.
(2)
Includes $37.8 million amortization of deferred costs of health insurer's fee and $22.5 million in other ACA fees.
(3) Includes tax benefit of $72.6 million, net of adjustments, as a result of a loss on the stock of one of our subsidiaries.
(4) Includes $84.7 million pretax asset impairment related to our assets held for sale in connection with the Cognizant Transaction and $21.1 million in pretax expenses primarily related to the Cognizant transaction.
(5) Includes $31.9 million amortization of deferred costs of health insurer's fee and $26.6 million in other ACA fees.
(6) Includes $3.8 million pretax asset impairment primarily related to our assets held for sale in connection with the Cognizant Transaction and $68.3 million in pretax expenses primarily related to the Cognizant Transaction.
(7) Includes $35.4 million amortization of deferred costs of health insurer's fee and $25.8 million in other ACA fees.
(8) The sum of the quarterly amounts may not equal the year-to-date amounts due to rounding.